Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Oncotarget | CUDC907 promotes apoptosis of NF2 Schwannoma cells

Oncotarget

July 26, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 19, 2022, entitled, “CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.” continue reading »

Oncotarget | Predicting cancer immunotherapy response from gut microbiomes using machine learning models

News

July 19, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 19, 2022, entitled, “Predicting cancer immunotherapy response from gut microbiomes using machine learning models.” continue reading »

How Heartburn Can Turn Into Esophageal Cancer, and a Possible Biomarker

Oncotarget

July 15, 2022
In a recent Oncotarget paper, researchers investigated telomere shortening in patients with Barrett's esophagus as a potential biomarker of high risk for esophageal cancer. continue reading »

Behind the Study: Molecular Characterization of Lung Carcinomas Expressing KK-LC-1

Spotlight

July 11, 2022
Dr. Robert Hsu from the University of Southern California, Norris Comprehensive Cancer Center, describes a recent research paper he co-authored that was published by Oncotarget, entitled, “Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.” continue reading »

Oncotarget | Role of germline variants in the metastasis of breast carcinomas

News

July 7, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on June 30, 2022, entitled, “Role of germline variants in the metastasis of breast carcinomas.” continue reading »